Evidence map›Paper›PMID 30027686›Full record

ArticleJournal of the International AIDS Society2018

HIV testing history and access to treatment among migrants living with HIV in Europe.

Ibidun Fakoya, Débora Álvarez-Del Arco, Susana Monge, Andrew J Copas, Anne-Francoise Gennotte, Alain Volny-Anne, Claudia Wengenroth, Giota Touloumi, Maria Prins, Henrique Barros and 5 more

Open access · goldAbstract read
In one paragraph

Article in Journal of the International AIDS Society, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed, 2 pooled it
3.0field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 2 syntheses or guidelines pooled it, 50 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Review
  4. Article
  5. Article
  6. Article
  7. Review
  8. Observational
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Observational
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 10 institutions in 10 countries.

Ibidun FakoyaInstitute for Global Health, University College London, London, United Kingdom.
Débora Álvarez-Del ArcoNational Centre of Epidemiology, Instituto de Salud Carlos III, Madrid, Spain.
Susana MongeDepartment of Health and Socio-medical Sciences, University of Alcalá, Alcalá de Henares, Madrid.
Andrew J CopasInstitute for Global Health, University College London, London, United Kingdom.
Anne-Francoise GennotteDepartment of Infectious Diseases, CHU Saint-Pierre, Brussels, Belgium.
Alain Volny-AnneEuropean AIDS Treatment Group.
Claudia WengenrothHIV Centre Frankfurt, Germany.
Giota TouloumiDepartment of Hygiene, Epidemiology& Medical Statistics, Medical School, National and Kapodistrian University of Athens, Athens, Greece.
Maria PrinsAcademic Medical Centre, University of Amsterdam, Amsterdam, the Netherlands.
Henrique BarrosFaculty of Medicine, University of Porto, Porto, Portugal.
Katharine Ea DarlingLausanne University Hospital, Lausanne, Switzerland.
Tullio PrestileoUnit for Infectious Diseases and Assistance, Coordination and Territorial Integration for Migrants' Emergency, Civico- Benfratelli Hospital, Palermo, Italy.
Julia Del AmoNational Centre of Epidemiology, Instituto de Salud Carlos III, Madrid, Spain.
Fiona M BurnsInstitute for Global Health, University College London, London, United Kingdom.
aMASE Study Team
University College London · GBInstituto de Salud Carlos III · ESAzienda di Rilievo Nazionale ed Alta Specializzazione · ITCardiovascular Center Frankfurt · DECentre Hospitalier Universitaire de Saint-Pierre · BENational and Kapodistrian University of Athens · GRTreatment Action Group · USUniversidade do Porto · PTUniversity of Amsterdam · NLUniversity of Lausanne · CH

Funding

Department of Health
6 · The paper itself

Abstract

introductionMigrants are overrepresented in the European HIV epidemic. We aimed to understand the barriers and facilitators to HIV testing and current treatment and healthcare needs of migrants living with HIV in Europe.

methodsA cross-sectional study was conducted in 57 HIV clinics in nine countries (Belgium, Germany, Greece, Italy, The Netherlands, Portugal, Spain, Switzerland and United Kingdom), July 2013 to July 2015. HIV-positive patients were eligible for inclusion if they were as follows: 18 years or older; foreign-born residents and diagnosed within five years of recruitment. Questionnaires were completed electronically in one of 15 languages and linked to clinical records. Primary outcomes were access to primary care and previous negative HIV test. Data were analysed using random effects logistic regression. Outcomes of interest are presented for women, heterosexual men and gay/bisexual men.

resultsA total of 2093 respondents (658 women, 446 heterosexual men and 989 gay/bisexual men) were included. The prevalence of a previous negative HIV test was 46.7%, 43.4% and 82.0% for women, heterosexual and gay/bisexual men respectively. In multivariable analysis previous testing was positively associated with: receipt of post-migration antenatal care among women, permanent residency among heterosexual men and identifying as gay rather than bisexual among gay/bisexual men. Access to primary care was found to be high (>83%) in all groups and was strongly associated with country of residence. Late diagnosis was common for women and heterosexual men (60.8% and 67.1%, respectively) despite utilization of health services prior to diagnosis. Across all groups almost three-quarters of people on antiretrovirals had an HIV viral load <50 copies/mL.

conclusionsMigrants access healthcare in Europe and while many migrants had previously tested for HIV, that they went on to test positive at a later date suggests that opportunities for HIV prevention are being missed. Expansion of testing beyond sexual health and antenatal settings is still required and testing opportunities should be linked with combination prevention measures such as access to PrEP and treatment as prevention.

Indexed as

AIDS SerodiagnosisHealth Services AccessibilityTransients and MigrantsAdultAnti-Retroviral AgentsBisexualityCross-Sectional StudiesEuropeFemaleHeterosexualityHIV InfectionsHumansLogistic ModelsMalePregnancyPrimary Health CareAnti-Retroviral Agentshealth services accessibilityHIVHIV serodiagnosismigrantsprimary healthcare

Identifiers

PMID30027686
PMCPMC6053481
OpenAlexW2884062542

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.